Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Herantis Pharma Logo
Herantis Pharma Growth Score
80
CB Rank
84298
Heat Score
68
Herantis Pharma A pharmaceutical company targeting unmet clinical needs.
Founded
obfuscation
PublicPost-IPO Equity Helsinki, Southern Finland, Finland11-50 herantis.com/
Biotechnology
Clinical Trials
Pharmaceutical
Overview

Herantis Pharma
Total Funding
obfuscation
Growth Score
80
Heat Score
68

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score80
-3 pts
in past quarter
Heat Score 68
9 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Herantis Pharma

CB Rank
84298
Herantis Pharma A pharmaceutical company targeting unmet clinical needs.
Founded
obfuscation
PublicPost-IPO Equity Helsinki, Southern Finland, Finland11-50 herantis.com/
Biotechnology
Clinical Trials
Pharmaceutical

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Grant
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Key People

Details

Legal Name HERANTIS PHARMA Plc
Operating Status Active
Stock Symbol  HEL:HRTIS
Company Type For Profit
Founders  Henri Huttunen
About the Company
Herantis Pharma A pharmaceutical company targeting unmet clinical needs.
Phone Number +358 9 222 1195
Contact Email ir@herantis.com
Predictions & Insights

Growth Insight

See this Growth Insight
Herantis Pharma is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Products & Services

HER-096
A subcutaneously administered peptidomimetic drug candidate designed to modify disease progression in Parkinson’s disease.
Lymfactin®
A gene therapy product in clinical development for treating breast cancer-associated lymphedema by promoting lymphatic vessel growth.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 10
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Herantis Pharma Logo
Post-IPO Equity - Herantis Pharma
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Herantis Pharma Logo
Post-IPO Equity - Herantis Pharma
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Herantis Pharma Logo
Post-IPO Equity - Herantis Pharma
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Herantis Pharma Logo
Post-IPO Equity - Herantis Pharma
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Herantis Pharma Logo
Post-IPO Equity - Herantis Pharma
—
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 10
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Herantis Pharma Logo
Post-IPO Equity - Herantis Pharma
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Herantis Pharma Logo
Post-IPO Equity - Herantis Pharma
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Herantis Pharma Logo
Post-IPO Equity - Herantis Pharma
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Herantis Pharma Logo
Post-IPO Equity - Herantis Pharma
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Herantis Pharma Logo
Post-IPO Equity - Herantis Pharma
—
obfuscation
— Post-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Michael J. Fox Foundation Logo
Michael J. Fox Foundation
Yes
Grant - Herantis Pharma Logo
Grant - Herantis Pharma
—
Michael J. Fox Foundation Logo
Michael J. Fox Foundation
Yes
Grant - Herantis Pharma Logo
Grant - Herantis Pharma
—
Michael J. Fox Foundation Logo
Michael J. Fox Foundation
Yes
Grant - Herantis Pharma Logo
Grant - Herantis Pharma
—
Michael J. Fox Foundation Logo
Michael J. Fox Foundation
Yes
Grant - Herantis Pharma Logo
Grant - Herantis Pharma
—
Michael J. Fox Foundation Logo
Michael J. Fox Foundation
Yes
Grant - Herantis Pharma Logo
Grant - Herantis Pharma
—

Investments

Number of Acquisitions 1

Investment Breakdown

Number of Acquisitions 1
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 2 Contacts 8

Employee Profiles

News

News and Press

News•Jun 25, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 2, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 16, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 5, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

725
22.47%
 in past month

Actively Used Products

10Herantis Pharma uses 10 technology products and services including HTML5, Google Analytics, and  Bootstrap, according to G2 Stack.

Active Website Tech Count

18Herantis Pharma is actively using 18 technologies for its website, according to BuiltWith. These include Google Font API, WordPress, and  Cloudflare.

Total IP

6The intellectual property of Herantis Pharma includes 4 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Herantis Pharma has registered 2 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Herantis Pharma's headquarters? Herantis Pharma is located in Helsinki, Southern Finland, Finland.Who invested in Herantis Pharma? Herantis Pharma has 4 investors including Michael J. Fox Foundation and  Parkinson's Virtual Biotech.When was the last funding round for Herantis Pharma? Herantis Pharma closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are Herantis Pharma's competitors? Alternatives and possible competitors to Herantis Pharma may include Canton Strategic Holdings, Cognition Therapeutics, and  Vigil Neuroscience.How much funding has Herantis Pharma raised to date? Herantis Pharma has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(6ec160d 1)
|